Ouch!
One business professor told The Day that Pfizer's problems show a corporate tendency to preserve management, rather than preserving the business itself. "Having finance people and lawyers without scientific knowledge who don't know a neutron from a crouton... making decisions about a viable research project is a problem," he said.
From "The Day."
No comments:
Post a Comment